Literature DB >> 15194259

Growth hormone deficiency and related disorders: insights into causation, diagnosis, and treatment.

Mehul Dattani1, Michael Preece.   

Abstract

Advances in molecular biology have led to the identification of mutations within several novel genes associated with the phenotype of isolated growth hormone deficiency, combined pituitary hormone deficiency, and syndromes such as septo-optic dysplasia. Progress has also been made in terms of the optimum diagnosis of disorders of stature and their treatment. The use of growth hormone for the treatment of adults with growth hormone deficiency and conditions such as Turner's syndrome, Prader-Willi syndrome, intrauterine growth restriction, and chronic renal failure has changed the practice of endocrinology, although cost-benefit implications remain to be established.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194259     DOI: 10.1016/S0140-6736(04)16413-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Predicting response to growth hormone treatment.

Authors:  Leena Patel; Peter E Clayton
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

Review 2.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 3.  Current guidelines for adult GH replacement.

Authors:  Mauro Doga; Stefania Bonadonna; Monica Gola; Sebastiano Bruno Solerte; Giovanni Amato; Carlo Carella; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

Review 4.  Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action.

Authors:  Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

5.  An RNA-independent linkage of noncoding transcription to long-range enhancer function.

Authors:  Eung Jae Yoo; Nancy E Cooke; Stephen A Liebhaber
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

Review 6.  GH deficiency as the most common pituitary defect after TBI: clinical implications.

Authors:  Vera Popovic
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

7.  Hyperphagia in male melanocortin 4 receptor deficient mice promotes growth independently of growth hormone.

Authors:  H Y Tan; F J Steyn; L Huang; M Cowley; J D Veldhuis; C Chen
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

8.  The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study.

Authors:  Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

Review 9.  [Congenital adrenal hyperplasia and growth hormone deficiency. Special care in transition to adulthood].

Authors:  H G Dörr; C Schöfl
Journal:  Internist (Berl)       Date:  2009-10       Impact factor: 0.743

Review 10.  [Growth hormone therapy in adults. Attempt to assess a decade of use].

Authors:  M Faust; C J Strasburger
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.